Researchers develop light-activated Parkinson’s drug

News

Author: Simge Eva DoganPublished: 18 July 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

light-activated

A new light-activated drug for treating Parkinson’s has been developed by a research team led by the University of Barcelona, Spain.

The drug – named MRS7145 – is placed within a brain implant and then activated by shining a light on it.

The effect of the newly developed drug was tested on live mice to see if it could improve their motor function. The results – published in ‘Journal of Controlled Release’ – showed that MRS7145 reduced tremors and seizures and improved the mice’s ability to walk.

Professor Francisco Ciruela, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, Spain, said he envisaged the drug being administered by smart phones, with “the doctor (controlling) in a precise manner the release of the most efficient dose of the active drug in the place of action”.

For more information on Parkinson’s research please visit the EPDA website.

Go Back

Share this story

Comments


Related articles


Europe

Heinz Becker MEP: “Europe must take action for people with Parkinson’s”

My PD Journey will remove hurdles to optimal Parkinson's treatment

READ MORE
Tim Peake Walter Reynecke

Global update

Astronaut in space tweets praise to the delight of Parkinson’s painter

Painter is over the moon to receive recognition from astronaut

READ MORE
Stuffed aubergine lead

Recipes & Nutrition

Provençale-style aubergine stuffed with ratatouille and vegetarian mince

Provençale dish with vegetarian mince served in half an aubergine

READ MORE